Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity

American Journal of Surgical Pathology

Volumn 21, Issue 8, 1997, Pages 936-940

  Dorfman, David M ^a   Shahsafaei, Aliakbar ^a   Chan, John K C ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

CD5; CD99; Immunohistochemistry; Mediastinum; Thymic carcinoma; Thymoma; Thymus

Indexed keywords

CD5 ANTIGEN; CD99 ANTIGEN; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CARCINOMA; CLEAR CELL CARCINOMA; CONTROLLED STUDY; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; SQUAMOUS CELL CARCINOMA; THYMOCYTE; THYMOMA; THYMUS CANCER;

ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD5; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEDIASTINAL NEOPLASMS; T-LYMPHOCYTES; THYMOMA; THYMUS GLAND; THYMUS NEOPLASMS;

EID: 0030826437     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199708000-00008     Document Type: Article

References (25)

1. Arber DA, Weiss LM. CD5: a review. Appl Immunohistochem 1995;3:1-22.
2. Berezowski K, Grimes MM, Kornstein MJ. CD5 in thymic carcinomas and CASTLE using paraffin embedded tissue [Abstract]. Mod Pathol 1996;8:153.
3. Bernatz, PE, Harrison EG, Clagett OT. Thymoma: clinicopathologic study. J Thorac Cardiovasc Surg 1961;42:424-44.
4. Chan JKC, Rosai J. Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol 1991;22:349-67.
5. Chan JKC, Tsang WYW, Seneviratne S, Pau MY. The MIC2 antibody O13: practical application for the study of thymic epithelial tumors. Am J Surg Pathol 1995;19:1115-23.
6. Chilosi M, Castelli P, Martignoni G, et al. Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen. Am J Surg Pathol 1992;16:988-97.
7. MIC2) immunoreactivity in the diagnosis of thymic epithelial neoplasms and mediastinal lymphoproliferative disorders: a study of paraffin sections using monoclonal antibody O13. Appl Immunohistochem 1996;4:34-42.
8. Gogolin-Ewens K, Meeusen E, Lee CS, Brandon M. Expression of CD5, a lymphocyte surface antigen on the endothelium of blood vessels. Eur J Immunol 1989;19:935-8.
9. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH. Depletion of CD4+ T cells in major histocompatibilily complex class-II deficient mice. Science 1991;253:1417-20.
10. Hasserjian RP, Klimstra DS, Rosai J. Carcinomas of the thymus with clear-cell features, report of eight cases and review of the literature. Am J Surg Pathol 1995;19:835-41.
11. Hishima T, Fukayama M, Fujisawa M, et al. CD5 expression in thymic carcinoma. Am J Pathol 1994;145:268-75.
12. Kirchner T, Muller-Hermelink HK. New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol 1989;10:167-89.
13. Kirchner T, Schalke B, Buchwald J, et al. Well-differentiated thymic carcinoma: an organo-typical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 1992;16:1153-69.
14. Lattes R. Thymomas and other tumors of the thymus, an analysis of 107 cases. Cancer 1962;15:1224-60.
15. Lewis JE, Wick MR, Scheithauer BW, Bernatz, PE, Taylor WF. Thymoma, a clinico-pathologic review. Cancer 1987;60:2727-43.
16. Marino M, Muller-Hermelink HK. Thymoma and thymic carcinoma: relation of thymoma epithelial cells to the cortical and medullary differentiation of the thymus. Virchows Arch [A] 1985;407: 119-49.
17. Moran CA, Suster S. Current status of the histologic classification of thymoma. Int J Surg Pathol 1995;3:67-72.
18. Moran CA, Suster S. Mucoepidermoid carcinomas of the thymus, a clinicopathologic study of six cases. Am J Surg Pathol 1995;19: 826-34.
19. Rosai J. Ackerman's Surgical Pathology. 8th ed. St. Louis: CV Mosby, 1996:435-91.
20. Snover DC, Levine GD, Rosai J. Thymic carcinoma: five distinctive histological variants. Am J Surg Pathol 1982;6:451-70.
21. Suster S, Rosai J. Thymic carcinoma: a clinicopathologic study of 60 cases. Cancer 1991;67:1025-32.
22. Van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 1991;351:662-5.
23. Walker AN, Mills SE, Fechner RE. Thymomas and thymic carcinomas. Semin Diagn Pathol 1990;7:250-65.
24. Wick MR, Rosai J. Neuroendocrine neoplasms of the mediastinum. Semin Diagn Pathol 1990;8:35-51.
25. Wick MR, Weiland LH, Scheithauer BW, Bernatz PE. Primary thymic carcinoma. Am J Surg Pathol 1982;6:613-30.